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ABSTRACT
Background – Personality disorder (PD) is associated with important health outcomes in the general popula-
tion. However, the length of diagnostic interviews poses a signiﬁcant barrier to obtaining large scale,
population-based data on PD. A brief screen for the identiﬁcation of people at high risk of PD in the general pop-
ulation could be extremely valuable for both clinicians and researchers.
Aim –We set out to validate the Standardised Assessment of Personality –Abbreviated Scale (SAPAS), in a general pop-
ulation sample, using the Structured Clinical Interviews for DSM-IV Personality Disorders (SCID-II) as a gold standard.
Method – One hundred and ten randomly selected, community-dwelling adults were administered the SAPAS
screening interview. The SCID-II was subsequently administered by a clinical interviewer blind to the initial
SAPAS score. Receiver operating characteristic analysis was used to assess the discriminatory performance of
the SAPAS, relative to the SCID-II.
Results – Area under the curve for the SAPAS was 0.70 (95% CI=0.60 to 0.80; p<0.001), indicating
moderate overall discriminatory accuracy. A cut point score of 4 on the SAPAS correctly classiﬁed 58% of par-
ticipants. At this cut point, the sensitivity and speciﬁcity were 0.69 and 0.53 respectively.
Conclusion – The SAPAS operates less efﬁciently as a screen in general population samples and is probably
most usefully applied in clinical populations. © 2015 The Authors Personality and Mental Health published
by John Wiley & Sons Ltd
Introduction
Personality disorder (PD) is a global health problem
(Tyrer et al., 2010). It is one of the hardest
psychiatric conditions to treat and is associated with
substantial morbidity and signiﬁcantly raised mortal-
ity from both natural and unnatural causes (Fok,
Stewart, Hayes, & Moran, 2014b; Fok et al., 2012).
At the level of the community, PD is a preva-
lent mental disorder associated with considerable†Joint senior authors
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public health burden. In the World Health Orga-
nization World Mental Health Surveys of DSM-
IV Personality Disorder, approximately 6% of
community participants from 13 high-income,
middle-income and low-income countries met
the criteria for a PD (Huang et al., 2009), al-
though other surveys have found higher preva-
lence ﬁgures of the order of 10–13% (Samuels,
2011; Torgersen, Kringlen, & Cramer, 2001). In
community settings, people with PD are more
likely to be separated or divorced, unemployed,
living in urban locations and are also more likely
to have concurrent health problems in the form
of mood, anxiety and substance use disorders
(Coid, Yang, Tyrer, Roberts, & Ullrich, 2006).
They also report a greater number of physical
health problems and are at particularly elevated risk
of cardiovascular disease (Moran et al., 2007). The
assessment of PD status therefore conveys valuable
information about the health status of members of
the general population. However, diagnostic inter-
views for PD are often lengthy and require special
training, and this poses a major obstacle to
obtaining large-scale, population-based data on
PD. Under such circumstances, an efﬁcient screen-
ing interview might be usefully applied, perhaps as
part of a two-stage procedure for case identiﬁcation
(Lenzenweger, Loranger, Korﬁne, & Neff, 1997).
The Standardised Assessment of Personality –
Abbreviated Scale (SAPAS) is a short and simple
interview-administered screen for PD. The
SAPAS was developed from the semi-structured
interview Standardised Assessment of Personality
(Mann, Jenkins, Cutting, & Cowen, 1981;
Moran, Rendu, Jenkins, Tylee, & Mann, 2001)
and validated in a sample of psychiatric patients,
where it was found to have good psychometric
properties, correctly identifying the presence of
PD in 90% of patients, with a sensitivity and spec-
iﬁcity of 0.94 and 0.85 respectively (Moran et al.,
2003). Subsequent ﬁeld testing of the SAPAS in
samples consisting of patients with substance
abuse (Gonzalez, 2014; Hesse & Moran, 2010;
Hesse, Rasmussen, & Pedersen, 2008), patients
with depression (Bukh, Bock, Vinberg, Gether, &
Kessing, 2010; Gorwood et al., 2010), probationers
(Pluck, Sirdiﬁeld, Brooker, & Moran, 2012) and
incarcerated adolescent boys (Kongerslev, Moran,
Bo, & Simonsen, 2012) have conﬁrmed the valid-
ity, reliability and clinical usefulness of the instru-
ment. The SAPAS was developed in a clinical
setting, and although the instrument has been used
outside secondary care (Buszewicz, Grifﬁn,
McMahon, Beecham, & King, 2010), to our
knowledge, no studies have examined the screen-
ing properties of the SAPAS when applied in a
general population setting. This paper reports re-
sults from a study of the performance of the
SAPAS in a general population sample.
Methods
Participants and sample size
We selected a random sample of participants
from a pool of adult participants of the South
East London Community Health study (SELCOH)
study (Hatch et al., 2011), a community survey of
psychiatric and physical morbidity. Details of the
SELCOH methodology have been described else-
where (Hatch et al., 2011). In brief, participants
were community residents in randomly selected
households located within the boroughs of
Southwark and Lambeth in South East London.
Wave 1 of the study took place from 2008 to
2010; follow-up (Wave 2) took place from 2011
to 2013. Ninety-four per cent (n=1596) of partici-
pants at Wave 1 agreed to be re-contacted at Wave
2. Participants for this study were selected on the
basis of their baseline SAPAS score at Wave 1.
The eligible pool for recruitment into this study
consisted of people who had complete SAPAS at
SELCOH Wave 1 and who consented to being
followed up at Wave 2 (n=1565). The Structured
Clinical Interview for DSM-IV Personality Disorders
SCID-II interviewing took place at Wave 2 (see
procedure in the subsequent discussion).
For the purposes of validating the SAPAS, we
wanted to ensure that we had a sufﬁcient number
of ‘true cases’ of PD. We therefore oversampled
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screen positive cases in order to estimate the sensi-
tivity and speciﬁcity with adequate precision. In
the original validation study (Moran et al.,
2003), a score of 3 or more on the SAPAS cor-
rectly identiﬁed the presence of PD in over 90%
of participants (sensitivity: 0.94; speciﬁcity:
0.85). A random sample of 70 individuals with a
SAPAS score of 3 or more would allow for the de-
tection of sensitivity of 0.94 with 95% conﬁdence
intervals of 0.86–0.98; in addition, a random
sample of 40 individuals with a SAPAS score of
less than 3 would allow for the detection of a spec-
iﬁcity of 0.85 with 95% conﬁdence intervals of
0.70–0.94. Based on these estimates, we randomly
selected 110 individuals for the study. There was
no statistically signiﬁcant difference in either the
age or gender of the 110 people randomly selected
for the study, compared with those not selected
from the eligible pool.
Measures
Screening measure. The SAPAS consists of eight
questions, corresponding to a descriptive state-
ment about the person. Each question is scored 0
(No)/1 (Yes), except for question 3 which is in-
versely scored 1 (No)/0 (Yes). The scores on the
eight items are added together to produce a total
score ranging between 0 and 8. The full text of
the questions can be found in the original SAPAS
validation study by Moran et al. (Moran et al.,
2003).
Reference standard. The SCID-II (First, Spitzer,
Gibbon, & Williams, 1995a) was selected as the
reference standard in this study. The SCID-II is
a 119-item semi-structured face-to-face interview.
Each item is scored as 1 (absent), 2 (subthresh-
old) or 3 (threshold). Questions may necessitate
further exploration by the interviewer in order
to score a particular item. If a threshold is reached
on a sufﬁcient number of items, the category of
PD is deemed to be present. The SCID–II was
designed to generate DSM–III–R diagnoses; how-
ever, by eliminating items for passive–aggressive
and depressive PDs, it can be used to generate
DSM–IV PD diagnoses.
Procedure. South East London Community
Health study participants were recruited between
2008 and 2010. Baseline screening with the
SAPAS was performed by interviewers as part
of a face-to-face interview battery. SCID-II
interviews were conducted in 2012 by a trained
clinical interviewer (M.F.) experienced in psy-
chiatric diagnosis, who was blind to the partici-
pant’s baseline SAPAS score. Participants were
paid £15 for giving up their time to participate
in the study. Written informed consent was
obtained from each participant prior to
interviewing.
Data analyses
The aim of the statistical analysis was to evaluate
the ability of SAPAS to discriminate between pa-
tients with and without DSM–IV Personality Dis-
orders (SCID). Towards this end, we used a
receiver operating characteristic (ROC) analysis
to assess the performance of the SAPAS and to
identify an appropriate general population cut-off
score on the SAPAS for predicting a diagnosis of
any PD (present or absent) on the SCID-II. An
ROC curve was obtained by plotting pairs of true
positives (sensitivity) against false positives (1—
speciﬁcity) for all possible cut-off scores on the
SAPAS. The area under the curve (AUC) was
calculated to provide an estimate of the screen’s
discriminatory performance. The sensitivity and
speciﬁcity of the SAPAS at different cut-off scores
was assessed using a sensitivity–speciﬁcity plot.
The internal consistency of the SAPAS was
assessed by calculating Cronbach’s alpha on the
total score after omitting each item and also over-
all. All analyses were performed using SAS v9.3
(SAS Institute, Cary, NC, USA). All p-values
given are two sided; the level of signiﬁcance was
set to 0.05.
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Results
All 110 participants who were randomly selected
and invited to participate in the study agreed to
take part. The mean age of the sample was
42.8 years (SD=15.7). Sixty-ﬁve (59%) were fe-
male, 72 (65%) were White, 21 (19%) were
Black-Caribbean or Black African and the re-
mainder (n=17; 15%) were from a range of
other ethnic groups. A total of 35 out of 110
persons received a SCID-II diagnosis of PD, giv-
ing an overall prevalence of 32%. The mean
number of PD diagnoses among those with any
PD was 1.4 (SD=0.65). The mean time in days
between SAPAS screening and SCID-II inter-
view was 948days (SD=202.6days, range 461
to 1327days).
Figure 1 displays the ROC curve for the
SAPAS as a screen for a SCID-II criterion diagno-
sis of any PD in the sample. The ROC curve for a
well-performing test deviates signiﬁcantly from the
45° reference line (AUC=0.5), where no discrim-
ination exists, and approaches the ‘ideal test point’
(AUC=1), where sensitivity and speciﬁcity both
equal 100% and the false positive rate is 0%
(Kongerslev et al., 2012; Kraemer, 1992). In our
sample, the ROC curve for the sample was statisti-
cally highly signiﬁcantly different (p<0.001) from
the 45° reference line. The AUC was 0.70 (95%
CI=0.60 to 0.80), indicating moderate overall
discriminatory accuracy, taking all possible cut
scores into account.
The performance of the SAPAS at a range of
cut-off scores is displayed in Table 1. These data,
together with the sensitivity–speciﬁcity plot
(Figure 2) revealed that the optimal SAPAS cut-
off score for a SCID-II-based diagnosis of PD was
4. A cut-off score of 4 had the best balance of sen-
sitivity and speciﬁcity and correctly classiﬁed 58%
of individuals.
Table 2 shows the alpha coefﬁcients of each
item from the SAPAS. The alpha coefﬁcient for
the total SAPAS score was 0.51, with ‘Generally
a perfectionist’ being the item that was least con-
sistent with the remaining items.
Discussion
To our knowledge, this is the ﬁrst attempt at vali-
dating a PD screening tool in a general population
sample. The study provides evidence of the perfor-
mance of the SAPAS as a screening measure for
PD in the general population. The ROC analysis
showed that the SAPAS has moderate discrimina-
tory accuracy (AUC=0.7) and a cut point of 4
provided the optimal balance between sensitivity
and speciﬁcity. However, this cut point correctly
Figure 1: Receiver operating characteristic (ROC) curve for
Standardised Assessment of Personality – Abbreviated Scale
(SAPAS) as a screen for any Structured Clinical Interviews
for DSM-IV Personality Disorder (SCID-II)
Table 1: Sensitivity, speciﬁcity and power to predict person-
ality disorder at different cut-off scores of the Standardised
Assessment of Personality – Abbreviated Scale
Cut-off
score
Sensi
tivity
Speci
ﬁcity
Positive
predictive
value
Negative
predictive
value
Correctly
classiﬁed
(%)
2 or more 0.89 0.27 0.36 0.83 46
3 or more 0.80 0.44 0.40 0.83 55
4 or more 0.69 0.53 0.41 0.78 58
5 or more 0.23 0.81 0.36 0.69 63
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classiﬁed the presence of PD in only 58% of partic-
ipants. In addition, the internal consistency of the
SAPAS in the general population was low
(α=0.51). Regarding this latter ﬁnding, it is im-
portant to stress that the internal consistency ob-
tained in this study is comparable with that
obtained in other samples (Germans, Van Heck,
Moran, & Hodiamont, 2008). Moreover, alpha
values are dependent on the number of scale items
and the dimensionality of the underlying con-
struct being measured (Kongerslev et al., 2012).
The SAPAS is screening for a heterogeneous
and multidimensional construct (the broad cate-
gory of PD), and we would therefore not antici-
pate a high level of internal consistency.
The ﬁndings should be considered in the light
of a number of limitations. The long time lag be-
tween SAPAS screen and SCID-II interview,
from a minimum of 15months to a maximum of
over 3 years, means it is possible that real change
in personality function occurred in some partici-
pants between initial SAPAS screening and subse-
quent SCID-II interview; this would have led to
substantial underestimation of the predictive
power of the SAPAS. In other words, the appar-
ent failure of the SAPAS to correctly identify a
sizeable proportion of people with PD in this study
may partially reﬂect underlying changes in the PD
status of the study participants over time.
Although the SCID-II is a widely used and well-
established instrument for diagnosing PD, our
choice of this measure as the ‘gold standard’
against which we validated the SAPAS could be
questioned, particularly as the test–retest reliabil-
ity of the instrument is less than optimal in non-
clinical samples (First et al., 1995b).
The study ﬁndings differ in some respects from
previous validation studies of the SAPAS. The
original study by Moran et al. (2003) validated
the SAPAS in adult psychiatric patients recruited
in outpatients, day-patients and inpatient units in
London, UK, and found that a cut point of 3 or 4
correctly classiﬁed PD in over 80% of participants,
with a cut point of 3 offering the best balance of
sensitivity (0.94) and speciﬁcity (0.85). Further
studies in samples of incarcerated adolescent boys
(Kongerslev et al., 2012) and probationers (Pluck
et al., 2012) found a cut point of 3 correctly iden-
tiﬁed PD in 86% and 78% of participants respec-
tively. Two studies using a self-report version of
the instrument, in psychiatric outpatients and in-
patients with substance dependence respectively,
both found the optimal cut point to be 4
(Germans et al., 2008; Gonzalez, 2014).
Figure 2: Sensitivity–speciﬁcity plot relating Structured
Clinical Interviews for DSM-IV Personality Disorder
(SCID-II) positive diagnosis to total score on the
Standardised Assessment of Personality – Abbreviated Scale
(SAPAS)
Table 2: The internal consistency of the Standardised As-
sessment of Personality – Abbreviated Scale
Item
Alpha coefﬁcient
if item omitted
Difﬁculty making
and keeping friends
0.47
Usually a loner 0.42
Trusting others 0.46
Normally loses temper easily 0.41
Normally impulsive 0.45
Normally a worrier 0.48
Depend on others a lot 0.47
Generally a perfectionist 0.58
The alpha coefﬁcient for the total score is 0.51
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Compared with these previous studies, our
study found that the SAPAS had a diminished
predictive power in a general population sample.
To date, the SAPAS has been applied primarily
to clinical samples, and our ﬁndings suggest this
is where its continued use is best justiﬁed. Our
ﬁndings concord with Morse and Pilkonis’ investi-
gation of the validity of three PD screening mea-
sures (Inventory of Interpersonal Problems
Personality Disorder Scale; Temperament and
Character Inventory Self-Directedness Scale; and
Iowa Personality Disorder Screen) in psychiatric
and non-psychiatric samples (Morse & Pilkonis,
2007), in which all three screening measures were
shown to be more effective in a psychiatric sample
than in a non-psychiatric sample—in the non-
psychiatric sample, none of the three screens had
a statistically signiﬁcant AUC, and diagnostic efﬁ-
ciencies (i.e. percentage correctly classiﬁed) were
in the range of 50–60%.
The difﬁculties of exporting screening mea-
sures, developed in clinical samples, to non-
clinical samples is likely a result of spectrum bias
(Ransohoff & Feinstein, 1978). The causes of
spectrum bias may include the following: (1) the
lower prevalence of the disease in the general pop-
ulation compared with clinical settings; (2) the
differences between disease-positive individuals
in the general community setting and those in a
clinical setting; and (3) the differences between
disease-negative individuals in the general com-
munity setting and those in a clinical setting. In
other words, apart from the difference in base rates
of the disease between the general population and
clinical settings, the phenomenon under investi-
gation may also differ qualitatively, much like
the controversy about whether the ‘nature’ of de-
pression—not only its severity—is different in pri-
mary care settings than in psychiatric settings
(Klinkman, 2003; Vuorilehto, Melartin, Rytsala,
& Isometsa, 2007). We detected a difference in
the severity of personality disturbance between in-
dividuals in our community study (where the
mean number of PD diagnoses was 1.4) compared
with individuals in a clinical population used in
the original validation study (where the mean
number of PD diagnoses was 2.1) (Moran et al.,
2003). In Morse and Pilkonis’ study (Morse &
Pilkonis, 2007), the test–retest reliability of
screeners was lower in non-psychiatric samples,
perhaps indicating that people with PD in non-
psychiatric samples have a lesser ﬁxity and perva-
siveness of personality pathology compared with
those in psychiatric samples.
The challenge for a screening tool to identify
cases from non-cases of PD should also be consid-
ered in the context of the number of PD diagnoses
represented in the DSM—the 10 different speciﬁc
single PD diagnosis and the possibility of a mixed
or comorbid presentation (Morse & Pilkonis,
2007). A screening tool that endeavours to screen
for the presence or absence of any PD has a much
higher aim than one screening for a speciﬁc single
PD.
Since its development in 2003, the SAPAS has
been widely applied in research and clinical
practice. Its key advantages over other PD measures
are as follows: it is a very rapid screen (taking less
than 2min to complete); does not require training;
is simple to use; and is acceptable to respondents.
Moreover, it has good predictive utility for a range
of clinical settings—for example, as a predictor of
response to antidepressant treatment (Gorwood
et al., 2010), in predicting dropout from specialist
services (Crawford et al., 2009), and as a marker
of problems in addiction populations (Hesse et al.,
2008). To our knowledge, no other PD screen has
had its performance tested in the general
population, and our ﬁndings suggest that the
SAPAS is best used in clinical samples. Neverthe-
less, the instrument may still have utility for
capturing personality dysfunction in large studies
of general populations (Fok et al., 2014a; Solmi,
Hatch, Hotopf, Treasure, & Micali, 2014).
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